Glaucoma persists as a leading cause of irreversible vision impairment, but recent developments in treatment have delivered new avenues for patients. Innovative therapies, such as targeted drug delivery systems and minimally invasive surgical procedures, are gaining traction, aiming to protect vision by lowering intraocular pressure more effectivel